nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Distress—Hydroxyurea—head and neck cancer	0.0416	0.0433	CcSEcCtD
Carbidopa—Common cold—Fluorouracil—head and neck cancer	0.0318	0.0331	CcSEcCtD
Carbidopa—Isoprenaline—MAPK1—head and neck cancer	0.0272	0.709	CrCbGaD
Carbidopa—Emotional distress—Hydroxyurea—head and neck cancer	0.0272	0.0282	CcSEcCtD
Carbidopa—Emotional distress—Fluorouracil—head and neck cancer	0.0196	0.0203	CcSEcCtD
Carbidopa—Blister—Hydroxyurea—head and neck cancer	0.016	0.0167	CcSEcCtD
Carbidopa—Numbness—Vinblastine—head and neck cancer	0.0153	0.0159	CcSEcCtD
Carbidopa—Sensory loss—Vinblastine—head and neck cancer	0.0146	0.0152	CcSEcCtD
Carbidopa—Extravasation—Vinblastine—head and neck cancer	0.0145	0.0151	CcSEcCtD
Carbidopa—Duodenal ulcer—Docetaxel—head and neck cancer	0.0124	0.0129	CcSEcCtD
Carbidopa—Heartburn—Fluorouracil—head and neck cancer	0.0121	0.0126	CcSEcCtD
Carbidopa—Blister—Fluorouracil—head and neck cancer	0.0115	0.012	CcSEcCtD
Carbidopa—Blood urea increased—Hydroxyurea—head and neck cancer	0.0109	0.0113	CcSEcCtD
Carbidopa—Phlebitis—Vinblastine—head and neck cancer	0.0107	0.0111	CcSEcCtD
Carbidopa—Numbness—Fluorouracil—head and neck cancer	0.01	0.0104	CcSEcCtD
Carbidopa—Sensory loss—Fluorouracil—head and neck cancer	0.00959	0.00998	CcSEcCtD
Carbidopa—Extravasation—Fluorouracil—head and neck cancer	0.00953	0.00991	CcSEcCtD
Carbidopa—Disorientation—Hydroxyurea—head and neck cancer	0.00937	0.00974	CcSEcCtD
Carbidopa—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00877	0.00912	CcSEcCtD
Carbidopa—Heartburn—Docetaxel—head and neck cancer	0.00872	0.00907	CcSEcCtD
Carbidopa—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00872	0.00907	CcSEcCtD
Carbidopa—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00785	0.00817	CcSEcCtD
Carbidopa—Euphoric mood—Fluorouracil—head and neck cancer	0.00714	0.00743	CcSEcCtD
Carbidopa—Depression—Vinblastine—head and neck cancer	0.00706	0.00735	CcSEcCtD
Carbidopa—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00698	0.00726	CcSEcCtD
Carbidopa—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00694	0.00722	CcSEcCtD
Carbidopa—Myocardial infarction—Vinblastine—head and neck cancer	0.00694	0.00722	CcSEcCtD
Carbidopa—Extravasation—Docetaxel—head and neck cancer	0.00688	0.00715	CcSEcCtD
Carbidopa—Disorientation—Fluorouracil—head and neck cancer	0.00674	0.00701	CcSEcCtD
Carbidopa—Agranulocytosis—Vinblastine—head and neck cancer	0.00661	0.00687	CcSEcCtD
Carbidopa—Weight increased—Hydroxyurea—head and neck cancer	0.00659	0.00686	CcSEcCtD
Carbidopa—Haemoglobin—Vinblastine—head and neck cancer	0.00639	0.00665	CcSEcCtD
Carbidopa—Haemorrhage—Vinblastine—head and neck cancer	0.00636	0.00661	CcSEcCtD
Carbidopa—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00633	0.00659	CcSEcCtD
Carbidopa—Hypoaesthesia—Vinblastine—head and neck cancer	0.00633	0.00658	CcSEcCtD
Carbidopa—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00631	0.00657	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00603	0.00627	CcSEcCtD
Carbidopa—Isoprenaline—CYP1A1—head and neck cancer	0.00586	0.152	CrCbGaD
Carbidopa—Haemoglobin—Hydroxyurea—head and neck cancer	0.00583	0.00606	CcSEcCtD
Carbidopa—Haemorrhage—Hydroxyurea—head and neck cancer	0.0058	0.00603	CcSEcCtD
Carbidopa—Hallucination—Hydroxyurea—head and neck cancer	0.00577	0.006	CcSEcCtD
Carbidopa—Ataxia—Fluorouracil—head and neck cancer	0.00567	0.0059	CcSEcCtD
Carbidopa—Alopecia—Vinblastine—head and neck cancer	0.00562	0.00584	CcSEcCtD
Carbidopa—Nasopharyngitis—Fluorouracil—head and neck cancer	0.0054	0.00561	CcSEcCtD
Carbidopa—Mesalazine—PTGS2—head and neck cancer	0.00534	0.139	CrCbGaD
Carbidopa—Dysphagia—Fluorouracil—head and neck cancer	0.00521	0.00542	CcSEcCtD
Carbidopa—Ill-defined disorder—Vinblastine—head and neck cancer	0.00514	0.00534	CcSEcCtD
Carbidopa—Alopecia—Hydroxyurea—head and neck cancer	0.00512	0.00533	CcSEcCtD
Carbidopa—Anaemia—Vinblastine—head and neck cancer	0.00512	0.00532	CcSEcCtD
Carbidopa—Phlebitis—Docetaxel—head and neck cancer	0.00505	0.00526	CcSEcCtD
Carbidopa—Malaise—Vinblastine—head and neck cancer	0.00499	0.00519	CcSEcCtD
Carbidopa—Leukopenia—Vinblastine—head and neck cancer	0.00495	0.00515	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00485	0.00504	CcSEcCtD
Carbidopa—Convulsion—Vinblastine—head and neck cancer	0.0048	0.00499	CcSEcCtD
Carbidopa—Hypertension—Vinblastine—head and neck cancer	0.00478	0.00497	CcSEcCtD
Carbidopa—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00468	0.00487	CcSEcCtD
Carbidopa—Anaemia—Hydroxyurea—head and neck cancer	0.00467	0.00485	CcSEcCtD
Carbidopa—Discomfort—Vinblastine—head and neck cancer	0.00466	0.00484	CcSEcCtD
Carbidopa—Hot flush—Docetaxel—head and neck cancer	0.00466	0.00484	CcSEcCtD
Carbidopa—Menopausal symptoms—Docetaxel—head and neck cancer	0.00462	0.0048	CcSEcCtD
Carbidopa—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00458	0.00477	CcSEcCtD
Carbidopa—Myocardial infarction—Fluorouracil—head and neck cancer	0.00456	0.00474	CcSEcCtD
Carbidopa—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00456	0.00474	CcSEcCtD
Carbidopa—Dermatitis bullous—Docetaxel—head and neck cancer	0.00456	0.00474	CcSEcCtD
Carbidopa—Malaise—Hydroxyurea—head and neck cancer	0.00455	0.00473	CcSEcCtD
Carbidopa—Urinary tract infection—Fluorouracil—head and neck cancer	0.00452	0.0047	CcSEcCtD
Carbidopa—Leukopenia—Hydroxyurea—head and neck cancer	0.00452	0.0047	CcSEcCtD
Carbidopa—Thrombocytopenia—Vinblastine—head and neck cancer	0.00442	0.0046	CcSEcCtD
Carbidopa—Convulsion—Hydroxyurea—head and neck cancer	0.00437	0.00455	CcSEcCtD
Carbidopa—Hyponatraemia—Docetaxel—head and neck cancer	0.00437	0.00455	CcSEcCtD
Carbidopa—Pain in extremity—Docetaxel—head and neck cancer	0.00435	0.00453	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00435	0.00453	CcSEcCtD
Carbidopa—Agranulocytosis—Fluorouracil—head and neck cancer	0.00434	0.00451	CcSEcCtD
Carbidopa—Anorexia—Vinblastine—head and neck cancer	0.00431	0.00448	CcSEcCtD
Carbidopa—Discomfort—Hydroxyurea—head and neck cancer	0.00425	0.00442	CcSEcCtD
Carbidopa—Haemoglobin—Fluorouracil—head and neck cancer	0.0042	0.00436	CcSEcCtD
Carbidopa—Rhinitis—Fluorouracil—head and neck cancer	0.00418	0.00435	CcSEcCtD
Carbidopa—Haemorrhage—Fluorouracil—head and neck cancer	0.00417	0.00434	CcSEcCtD
Carbidopa—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00415	0.00432	CcSEcCtD
Carbidopa—Oedema—Hydroxyurea—head and neck cancer	0.00412	0.00428	CcSEcCtD
Carbidopa—Ataxia—Docetaxel—head and neck cancer	0.00409	0.00426	CcSEcCtD
Carbidopa—Infection—Hydroxyurea—head and neck cancer	0.00409	0.00426	CcSEcCtD
Carbidopa—Paraesthesia—Vinblastine—head and neck cancer	0.00406	0.00422	CcSEcCtD
Carbidopa—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00403	0.0042	CcSEcCtD
Carbidopa—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00398	0.00414	CcSEcCtD
Carbidopa—Anorexia—Hydroxyurea—head and neck cancer	0.00393	0.00408	CcSEcCtD
Carbidopa—Decreased appetite—Vinblastine—head and neck cancer	0.00393	0.00408	CcSEcCtD
Carbidopa—Cramp muscle—Docetaxel—head and neck cancer	0.00392	0.00408	CcSEcCtD
Carbidopa—Nasopharyngitis—Docetaxel—head and neck cancer	0.00389	0.00405	CcSEcCtD
Carbidopa—Constipation—Vinblastine—head and neck cancer	0.00386	0.00402	CcSEcCtD
Carbidopa—Pain—Vinblastine—head and neck cancer	0.00386	0.00402	CcSEcCtD
Carbidopa—Dysphagia—Docetaxel—head and neck cancer	0.00376	0.00391	CcSEcCtD
Carbidopa—Feeling abnormal—Vinblastine—head and neck cancer	0.00372	0.00387	CcSEcCtD
Carbidopa—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00369	0.00384	CcSEcCtD
Carbidopa—Alopecia—Fluorouracil—head and neck cancer	0.00369	0.00384	CcSEcCtD
Carbidopa—Dyspnoea—Hydroxyurea—head and neck cancer	0.00367	0.00382	CcSEcCtD
Carbidopa—Somnolence—Hydroxyurea—head and neck cancer	0.00366	0.00381	CcSEcCtD
Carbidopa—Dyspepsia—Hydroxyurea—head and neck cancer	0.00363	0.00377	CcSEcCtD
Carbidopa—Decreased appetite—Hydroxyurea—head and neck cancer	0.00358	0.00372	CcSEcCtD
Carbidopa—Abdominal pain—Vinblastine—head and neck cancer	0.00357	0.00371	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00356	0.0037	CcSEcCtD
Carbidopa—Fatigue—Hydroxyurea—head and neck cancer	0.00355	0.00369	CcSEcCtD
Carbidopa—Pain—Hydroxyurea—head and neck cancer	0.00352	0.00366	CcSEcCtD
Carbidopa—Constipation—Hydroxyurea—head and neck cancer	0.00352	0.00366	CcSEcCtD
Carbidopa—Weight increased—Docetaxel—head and neck cancer	0.00343	0.00356	CcSEcCtD
Carbidopa—Vision blurred—Fluorouracil—head and neck cancer	0.00342	0.00356	CcSEcCtD
Carbidopa—Weight decreased—Docetaxel—head and neck cancer	0.00341	0.00354	CcSEcCtD
Carbidopa—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0034	0.00353	CcSEcCtD
Carbidopa—Anaemia—Fluorouracil—head and neck cancer	0.00336	0.00349	CcSEcCtD
Carbidopa—Hypersensitivity—Vinblastine—head and neck cancer	0.00333	0.00346	CcSEcCtD
Carbidopa—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00331	0.00344	CcSEcCtD
Carbidopa—Myocardial infarction—Docetaxel—head and neck cancer	0.00329	0.00342	CcSEcCtD
Carbidopa—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00329	0.00342	CcSEcCtD
Carbidopa—Body temperature increased—Hydroxyurea—head and neck cancer	0.00326	0.00339	CcSEcCtD
Carbidopa—Leukopenia—Fluorouracil—head and neck cancer	0.00325	0.00338	CcSEcCtD
Carbidopa—Asthenia—Vinblastine—head and neck cancer	0.00324	0.00337	CcSEcCtD
Carbidopa—Convulsion—Fluorouracil—head and neck cancer	0.00315	0.00327	CcSEcCtD
Carbidopa—Agranulocytosis—Docetaxel—head and neck cancer	0.00313	0.00326	CcSEcCtD
Carbidopa—Chest pain—Fluorouracil—head and neck cancer	0.00309	0.00322	CcSEcCtD
Carbidopa—Diarrhoea—Vinblastine—head and neck cancer	0.00309	0.00321	CcSEcCtD
Carbidopa—Discomfort—Fluorouracil—head and neck cancer	0.00306	0.00318	CcSEcCtD
Carbidopa—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00304	0.00316	CcSEcCtD
Carbidopa—Haemoglobin—Docetaxel—head and neck cancer	0.00303	0.00315	CcSEcCtD
Carbidopa—Rhinitis—Docetaxel—head and neck cancer	0.00302	0.00314	CcSEcCtD
Carbidopa—Haemorrhage—Docetaxel—head and neck cancer	0.00301	0.00313	CcSEcCtD
Carbidopa—Hypoaesthesia—Docetaxel—head and neck cancer	0.003	0.00312	CcSEcCtD
Carbidopa—Confusional state—Fluorouracil—head and neck cancer	0.00299	0.00311	CcSEcCtD
Carbidopa—Dizziness—Vinblastine—head and neck cancer	0.00299	0.00311	CcSEcCtD
Carbidopa—Urinary tract disorder—Docetaxel—head and neck cancer	0.00298	0.00309	CcSEcCtD
Carbidopa—Oedema—Fluorouracil—head and neck cancer	0.00297	0.00308	CcSEcCtD
Carbidopa—Asthenia—Hydroxyurea—head and neck cancer	0.00296	0.00307	CcSEcCtD
Carbidopa—Urethral disorder—Docetaxel—head and neck cancer	0.00295	0.00307	CcSEcCtD
Carbidopa—Infection—Fluorouracil—head and neck cancer	0.00295	0.00306	CcSEcCtD
Carbidopa—Thrombocytopenia—Fluorouracil—head and neck cancer	0.0029	0.00302	CcSEcCtD
Carbidopa—Vomiting—Vinblastine—head and neck cancer	0.00287	0.00299	CcSEcCtD
Carbidopa—Headache—Vinblastine—head and neck cancer	0.00283	0.00294	CcSEcCtD
Carbidopa—Anorexia—Fluorouracil—head and neck cancer	0.00283	0.00294	CcSEcCtD
Carbidopa—Diarrhoea—Hydroxyurea—head and neck cancer	0.00282	0.00293	CcSEcCtD
Carbidopa—Flushing—Docetaxel—head and neck cancer	0.0028	0.00291	CcSEcCtD
Carbidopa—Hypotension—Fluorouracil—head and neck cancer	0.00277	0.00288	CcSEcCtD
Carbidopa—Dizziness—Hydroxyurea—head and neck cancer	0.00272	0.00283	CcSEcCtD
Carbidopa—Nausea—Vinblastine—head and neck cancer	0.00268	0.00279	CcSEcCtD
Carbidopa—Insomnia—Fluorouracil—head and neck cancer	0.00268	0.00279	CcSEcCtD
Carbidopa—Paraesthesia—Fluorouracil—head and neck cancer	0.00266	0.00277	CcSEcCtD
Carbidopa—Alopecia—Docetaxel—head and neck cancer	0.00266	0.00277	CcSEcCtD
Carbidopa—Dyspnoea—Fluorouracil—head and neck cancer	0.00264	0.00275	CcSEcCtD
Carbidopa—Mental disorder—Docetaxel—head and neck cancer	0.00264	0.00274	CcSEcCtD
Carbidopa—Somnolence—Fluorouracil—head and neck cancer	0.00264	0.00274	CcSEcCtD
Carbidopa—Vomiting—Hydroxyurea—head and neck cancer	0.00262	0.00272	CcSEcCtD
Carbidopa—Dyspepsia—Fluorouracil—head and neck cancer	0.00261	0.00271	CcSEcCtD
Carbidopa—Rash—Hydroxyurea—head and neck cancer	0.0026	0.0027	CcSEcCtD
Carbidopa—Dermatitis—Hydroxyurea—head and neck cancer	0.0026	0.0027	CcSEcCtD
Carbidopa—Headache—Hydroxyurea—head and neck cancer	0.00258	0.00268	CcSEcCtD
Carbidopa—Decreased appetite—Fluorouracil—head and neck cancer	0.00258	0.00268	CcSEcCtD
Carbidopa—Dysgeusia—Docetaxel—head and neck cancer	0.00257	0.00267	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00256	0.00266	CcSEcCtD
Carbidopa—Back pain—Docetaxel—head and neck cancer	0.00254	0.00264	CcSEcCtD
Carbidopa—Pain—Fluorouracil—head and neck cancer	0.00254	0.00264	CcSEcCtD
Carbidopa—Muscle spasms—Docetaxel—head and neck cancer	0.00252	0.00262	CcSEcCtD
Carbidopa—Nausea—Hydroxyurea—head and neck cancer	0.00245	0.00255	CcSEcCtD
Carbidopa—Feeling abnormal—Fluorouracil—head and neck cancer	0.00244	0.00254	CcSEcCtD
Carbidopa—Anaemia—Docetaxel—head and neck cancer	0.00242	0.00252	CcSEcCtD
Carbidopa—Urticaria—Fluorouracil—head and neck cancer	0.00236	0.00245	CcSEcCtD
Carbidopa—Syncope—Docetaxel—head and neck cancer	0.00235	0.00245	CcSEcCtD
Carbidopa—Leukopenia—Docetaxel—head and neck cancer	0.00235	0.00244	CcSEcCtD
Carbidopa—Body temperature increased—Fluorouracil—head and neck cancer	0.00234	0.00244	CcSEcCtD
Carbidopa—Palpitations—Docetaxel—head and neck cancer	0.00232	0.00241	CcSEcCtD
Carbidopa—Loss of consciousness—Docetaxel—head and neck cancer	0.00231	0.0024	CcSEcCtD
Carbidopa—Cough—Docetaxel—head and neck cancer	0.00229	0.00238	CcSEcCtD
Carbidopa—Convulsion—Docetaxel—head and neck cancer	0.00227	0.00236	CcSEcCtD
Carbidopa—Hypertension—Docetaxel—head and neck cancer	0.00226	0.00235	CcSEcCtD
Carbidopa—Chest pain—Docetaxel—head and neck cancer	0.00223	0.00232	CcSEcCtD
Carbidopa—Hypersensitivity—Fluorouracil—head and neck cancer	0.00218	0.00227	CcSEcCtD
Carbidopa—Dry mouth—Docetaxel—head and neck cancer	0.00218	0.00227	CcSEcCtD
Carbidopa—Confusional state—Docetaxel—head and neck cancer	0.00216	0.00224	CcSEcCtD
Carbidopa—Oedema—Docetaxel—head and neck cancer	0.00214	0.00223	CcSEcCtD
Carbidopa—Infection—Docetaxel—head and neck cancer	0.00213	0.00221	CcSEcCtD
Carbidopa—Shock—Docetaxel—head and neck cancer	0.00211	0.00219	CcSEcCtD
Carbidopa—Pruritus—Fluorouracil—head and neck cancer	0.0021	0.00218	CcSEcCtD
Carbidopa—Thrombocytopenia—Docetaxel—head and neck cancer	0.0021	0.00218	CcSEcCtD
Carbidopa—Anorexia—Docetaxel—head and neck cancer	0.00204	0.00212	CcSEcCtD
Carbidopa—Diarrhoea—Fluorouracil—head and neck cancer	0.00203	0.00211	CcSEcCtD
Carbidopa—Hypotension—Docetaxel—head and neck cancer	0.002	0.00208	CcSEcCtD
Carbidopa—Dizziness—Fluorouracil—head and neck cancer	0.00196	0.00204	CcSEcCtD
Carbidopa—Insomnia—Docetaxel—head and neck cancer	0.00194	0.00201	CcSEcCtD
Carbidopa—Paraesthesia—Docetaxel—head and neck cancer	0.00192	0.002	CcSEcCtD
Carbidopa—Dyspnoea—Docetaxel—head and neck cancer	0.00191	0.00198	CcSEcCtD
Carbidopa—Somnolence—Docetaxel—head and neck cancer	0.0019	0.00198	CcSEcCtD
Carbidopa—Vomiting—Fluorouracil—head and neck cancer	0.00189	0.00196	CcSEcCtD
Carbidopa—Dyspepsia—Docetaxel—head and neck cancer	0.00188	0.00196	CcSEcCtD
Carbidopa—Rash—Fluorouracil—head and neck cancer	0.00187	0.00194	CcSEcCtD
Carbidopa—Dermatitis—Fluorouracil—head and neck cancer	0.00187	0.00194	CcSEcCtD
Carbidopa—Decreased appetite—Docetaxel—head and neck cancer	0.00186	0.00193	CcSEcCtD
Carbidopa—Headache—Fluorouracil—head and neck cancer	0.00186	0.00193	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00185	0.00192	CcSEcCtD
Carbidopa—Fatigue—Docetaxel—head and neck cancer	0.00185	0.00192	CcSEcCtD
Carbidopa—Constipation—Docetaxel—head and neck cancer	0.00183	0.0019	CcSEcCtD
Carbidopa—Pain—Docetaxel—head and neck cancer	0.00183	0.0019	CcSEcCtD
Carbidopa—Feeling abnormal—Docetaxel—head and neck cancer	0.00176	0.00183	CcSEcCtD
Carbidopa—Nausea—Fluorouracil—head and neck cancer	0.00176	0.00183	CcSEcCtD
Carbidopa—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00175	0.00182	CcSEcCtD
Carbidopa—Body temperature increased—Docetaxel—head and neck cancer	0.00169	0.00176	CcSEcCtD
Carbidopa—Abdominal pain—Docetaxel—head and neck cancer	0.00169	0.00176	CcSEcCtD
Carbidopa—Hypersensitivity—Docetaxel—head and neck cancer	0.00158	0.00164	CcSEcCtD
Carbidopa—Asthenia—Docetaxel—head and neck cancer	0.00154	0.0016	CcSEcCtD
Carbidopa—Pruritus—Docetaxel—head and neck cancer	0.00151	0.00157	CcSEcCtD
Carbidopa—Diarrhoea—Docetaxel—head and neck cancer	0.00146	0.00152	CcSEcCtD
Carbidopa—Dizziness—Docetaxel—head and neck cancer	0.00142	0.00147	CcSEcCtD
Carbidopa—Vomiting—Docetaxel—head and neck cancer	0.00136	0.00142	CcSEcCtD
Carbidopa—Rash—Docetaxel—head and neck cancer	0.00135	0.0014	CcSEcCtD
Carbidopa—Dermatitis—Docetaxel—head and neck cancer	0.00135	0.0014	CcSEcCtD
Carbidopa—Headache—Docetaxel—head and neck cancer	0.00134	0.00139	CcSEcCtD
Carbidopa—Nausea—Docetaxel—head and neck cancer	0.00127	0.00132	CcSEcCtD
